Company Monitoring Page for Novo Nordisk

job ratings for Novo Nordisk

02/06/25
industry:
company:
Novo Nordisk
job rating:
2
3 semaglutide products account for around 70% of Novo Nordisk sales. This makes the company vulnerable, and considering dominant economic position of the company in Danish national economy, it brings a serious risk for the country. Yet the company continues to do sleepwalking dragging the happiest nation into a hole, particularly that peptide patents are not difficult to overcome. Counting on lousy competitors may not be the best strategy at all.
02/04/25
industry:
company:
Novo Nordisk
job rating:
1
The company uses various discriminatory practices, and it is enough to contact ex-employees or retirees to obtain information.
01/31/25
industry:
company:
Novo Nordisk
job rating:
1
Novo Nordisk internal consultants are combined into a small department and they often come from McKinsey, eg. are McKinsey dropouts. Company keeps them in high regards due to the reputation of that consulting company. Currently they try to dazzle coworkers at Novo by producing generalized reports with impressive McKinsey vocabulary, but using various AI bots and putting minimum effort into this work. Not much of value, though.
01/28/25
industry:
company:
Novo Nordisk
job rating:
1
We watch in dismay how the company conducts acquisitions and collaborations. Throwing money into unworthy partners. It tells there are no M&A skills in organization, no good know how in-house to evaluate technical and scientific value combined with some lack of local skills. Too many general managers, not enough technology managers. But hey, the markets are booming and competitors are even worse.
01/26/25
industry:
company:
Novo Nordisk
job rating:
1
Big news how successfully we can help gluttons. And what profits this would bring so stock went up. Really nothing to celebrate. Do we want to treat a patient?
01/20/25
industry:
company:
Novo Nordisk
job rating:
2
The image part, on surface all looks great, including token DEI images of happy workforce. Inside there is nationalism, collusion with own government, cronyism and even discrimination. Boasting wealth and comparing to budget of own government happened. Reason to work together. Many managers have come from local industries or government branches with no experience in biopharma. Too many managers, often covering narrow or artificial divisions. Poor collaboration with overseas operations. Superficial push towards modernization and giving this great publicity. Often can beat competition since apparently they are even in a worse shape. With oversized workforce company can play social public relations game offering employees long family leave benefits. This is possible since there are no serious domestic competitors and government tolerates and likes such monopoly if it keeps part of population happy. Often making wrong decisions in M&A or collaborations that come from excessive profits and available funding.
01/19/25
industry:
company:
Novo Nordisk
job rating:
1
2025 Davos is coming. The company is also enamored with Global Lighthouse Network by World Economic Forum. We know what that Forum represents. USA has DeepState. WEF is DeepGlobalism.
01/19/25
industry:
company:
Novo Nordisk
job rating:
2
Overstaffed, micromanaged, with gaps in competencies. Bizarre idea of hiring McKinsey dropouts and let them meddling with company activities.
01/17/25
company:
Novo Nordisk
job rating:
3
Lilly and Novo competition and comparison can be an interesting subject. Each one operates in different reality. Novo Nordisk lives in its own bubble of virtual reality with government involved. Both are very protective regarding national interests. Most of Novo managers get indoctrinated at Copenhagen Business School. Lilly is more chaotic, American business style. Both make a lot of in profit from American Healthcare system, at the end from American patients and taxpayers. Novo Nordisk employees enjoy better benefits, for example long parental leave. Both companies have problems, but this is a long story to tell.
12/16/23
industry:
company:
Novo Nordisk
job rating:
2
Wasting resources left and right
12/13/23
industry:
company:
Novo Nordisk
job rating:
1
Ethos or etoh
12/11/23
industry:
company:
Novo Nordisk
job rating:
2
Abundant resources now. Unfortunately mismanaged
11/07/23
industry:
company:
Novo Nordisk
job rating:
1
Ills of foundations combined with unexpected success. Filling illusionary positions around foundation main location and at the same time experiencing manufacturing problems.
10/18/23
industry:
company:
Novo Nordisk
job rating:
2
Got bubbles because of one simple molecule. Golden egg in unprepared nest
10/17/23
industry:
company:
Novo Nordisk
job rating:
2
Excels in misusing people skills and experience
10/16/23
industry:
company:
Novo Nordisk
job rating:
2
Many new managers who do not know what they do not know
09/12/22
industry:
company:
Novo Nordisk
job rating:
1
It goes all the way up to Vice President. Totally ego driven, not too intelligent
08/15/22
industry:
company:
Novo Nordisk
job rating:
7
Great company leasing the way!
07/29/22
company:
Novo Nordisk
job rating:
7
Stability and Nobel technology.
12/05/21
industry:
job title:
Executive Sales Rep
company:
Novo Nordisk
job rating:
1
Management is awful. There is so many levels of incompetency and they just paid out our Obesity sales force 50k in one quarter in bonus--they forecasted wrong and had to pull the voucher/coupon card off market. Total mess. Well the other sales force Diabetes got maybe 7k. Now they are sending a bunch of people to Las Vegas for a live meeting. Majority of people dont want to go, layers of incompetence. Layers

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.